Avani M Singh (Rohit K Jain)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Avani M Singh, Rafael Rubiera-Pebe, Yaser Ahmad, Michael Shafique, J Kevin Hicks, Tawee Tanvetyanon
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer. JCO oncology practice (2023)
Avani M Singh, Jose A Guevara-Patino, Xuefeng Wang, Roger Li, Guru Sonpavde, Avani M Singh
Antibody-Drug Conjugates in the Treatment of Urothelial Cancer. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Rami S Komrokji, Avani M Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E Lancet, David A Sallman
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome. Blood cancer journal 12 (11) (2022)